Eli Lilly ramps up its fight against imitation weight-loss drugs
The maker of blockbuster appetite-suppressing drugs Mounjaro and Zepbound is seeking to end a regulatory designation that has ...
Eli Lilly cutting cost of certain weight loss drugs by at least 50%
Eli Lilly is cutting the cost of certain weight loss drugs, with new single-dose vials costing less than other medications ...
The Motley Fool4d
These 3 Factors Could Make Eli Lilly Stock a Better Buy Than Novo Nordisk Right Now
Eli Lilly and Novo Nordisk compete in a handful of different markets ... is so intense in the U.S. that for months ...
Insider Monkey4d
Eli Lilly and Company (LLY): Jim Cramer’s Go-To Stock For Success
In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against Jim Cramer’s other go-to stocks for success. In a recent episode of Mad Money, Jim Cramer ...
Yahoo Finance4d
Eli Lilly and Company (LLY)
Eli Lilly and Company (NYSE: LLY) today announced Zepbound® (tirzepatide) 2.5 mg and 5 mg single-dose vials are available for self-pay for patients with an on-label prescription, significantly ...
Eli Lilly raises price of Zepbound while trumpeting discount on starter vials
Lilly announced that it will now sell Zepbound in vials, too. And a month's supply of vials with the 2.5 mg doses will cost ...